neurotrials.wordpress.com
| Page 2
https://neurotrials.wordpress.com/page/2
New Finding Could Lead to New Therapy for Multiple Sclerosis. August 1, 2012. Researchers at the Wayne State University School of Medicine, working with colleagues in Canada, have found that one or more substances produced by a type of immune cell in people with multiple sclerosis (MS) may play a role in the disease’s progression. The finding could lead to new targeted therapies for MS treatment. 8220;We think this is a very significant finding, particularly for the damage to the cerebral cortex seen in ...
neurotrials.wordpress.com
Industry Professionals |
https://neurotrials.wordpress.com/industry-professionals
Clinical Trial Enrollment Results. Our recruitment team uses comprehensive and aggressive strategies, including:. A large and constantly growing patient database. Strategic advertising tactics which may include television, radio, newspaper, magazines, and the internet. An extensive physician referral system. Relationships with area support groups (Narcolepsy, Headache, Alzheimer’s, Senior Citizens and more.). Community education seminars regarding clinical research. Leave a Reply Cancel reply. Call 404-8...
neurotrials.wordpress.com
September | 2012 |
https://neurotrials.wordpress.com/2012/09
NeuroTrials Crew Mucking In for MS Research! September 27, 2012. Katy McNulty is the Outreach Coordinator for NeuroTrials Research. Katy will be guest posting on the NeuroTrials blog, providing readers with a closer look into what it means to participate in the clinical research community. Next Saturday, October 6, a brave crew of NeuroTrials. Finest will be getting down and dirty at the National Multiple Sclerosis Society’s Muck Ruckus Event. How did we get into this? It seemed only natural! Our office ...
neurotrials.wordpress.com
Wall Street Journal Discusses New Sleep Drug with NeuroTrials CEO Dr. Russell Rosenberg |
https://neurotrials.wordpress.com/2013/06/25/wall-street-journal-discusses-new-sleep-drug-with-neurotrials-ceo-dr-russell-rosenberg
Wall Street Journal Discusses New Sleep Drug with NeuroTrials CEO Dr. Russell Rosenberg. The Wall Street Journal discussed the new insomnia sleep drug, suvorexant, scheduled to hit shelves in the coming months with NeuroTrials CEO and Chair of the National Sleep Foundation, Dr. Russell Rosenberg. To read the full article, click here. This entry was posted on Tuesday, June 25th, 2013 at 10:43 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0. NeuroTrials R...
neurotrials.wordpress.com
Dr. Rosenberg Appears on NPR “Morning Edition” |
https://neurotrials.wordpress.com/2012/08/27/543
Dr Rosenberg Appears on NPR “Morning Edition”. Atlanta School of Sleep Medicine. CEO Dr. Russell Rosenberg joined the NPR. Show today to discuss sleepwalkers. An excerpt from the interview is below:. Though a sleepwalker’s brain might be partially awake, most sleepwalkers have no memory of their episodes, and that’s a key feature, says Russell Rosenberg. For the full transcript of the interview or to listen online, click here. You can follow any responses to this entry through the RSS 2.0. Call 404-851-9...
neurotrials.wordpress.com
July | 2012 |
https://neurotrials.wordpress.com/2012/07
Huffington Post: Narcolepsy Remains Misunderstood and Underdiagnosed. July 20, 2012. Do you have narcolepsy? And Atlanta School of Sleep Medicine. CEO Dr. Russell Rosenberg. Discusses the misconceptions of narcolepsy that lead to underdiagnosis in his new article with the Huffington Post. Narcolepsy usually begins in the teens or early 20s, and all of the symptoms do not emerge simultaneously. AWAKEN. Follow all Dr. Rosenberg’s posts. NeuroTrials Conducting New RLS Research. July 18, 2012. The primary sy...
neurotrials.wordpress.com
October | 2012 |
https://neurotrials.wordpress.com/2012/10
Writhing and Rolling from Restless Legs? Learn About the Sleep Disorder and New Research. October 29, 2012. Restless legs syndrome (RLS) is a condition in which your legs feel extremely uncomfortable, usually while you’re sitting or lying down. Essentially, it makes you feel like getting up and moving around. Once you start moving, the unpleasant feeling of restless legs syndrome temporarily goes away. If you happen to suffer from RLS, learn about our new research study below. New RLS Research Study.
neurotrials.wordpress.com
June | 2013 |
https://neurotrials.wordpress.com/2013/06
Wall Street Journal Discusses New Sleep Drug with NeuroTrials CEO Dr. Russell Rosenberg. June 25, 2013. The Wall Street Journal discussed the new insomnia sleep drug, suvorexant, scheduled to hit shelves in the coming months with NeuroTrials CEO and Chair of the National Sleep Foundation, Dr. Russell Rosenberg. To read the full article, click here. Join the Search To End Alzheimer’s Disease. June 20, 2013. Alzheimer’s disease was first identified more than 100 years ago, but research into its symptoms, c...
SOCIAL ENGAGEMENT